Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.93 |
| ▸ | GAA | P10253 | 5/20 | 0.81 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 5/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | NSD2 | O96028 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | MPI | P34949 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etocarlide SCHEMBL122903 | 0.98 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL27611 | 0.98 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL2995239 | 0.96 | MAPT (0.93) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL11074653 | 0.96 | MAPT (0.93) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL9367891 | 0.96 | MAPT (0.93) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL6513773 | 0.96 | MAPT (0.93) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL103618 | 0.96 | MAPT (1.00) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL9263 | 0.96 | MAPT (1.00) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL250651 | 0.95 | MAPT (0.89) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL29187 | 0.94 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116814041-A | Waterproof flame-retardant cable | 瑞鑫集团有限公司 | 2023-09-29 | — | — | CN | claimed |
| EP-0031805-B1 | HARD BODY, ESPECIALLY HARD METAL WEARING PART, AND PROCESS FOR ITS PRODUCTION | VEREINIGTE EDELSTAHLWERKE AKTIENGESELLSCHAFT (VEW) (AT) | 1984-09-19 | — | — | EP | claimed |
| CN-116814041-A | Waterproof flame-retardant cable | 瑞鑫集团有限公司 | 2023-09-29 | — | — | CN | disclosed |
| US-11306085-B2 | Method for preparing pyrimidone heteroaryl derivative and intermediate of pyrimidone heteroaryl derivative | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2022-04-19 | — | — | US | disclosed |
| CN-113388319-B | High-wear-resistance chair | 宁波市鑫晟工贸实业有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-109748303-B | Preparation method of high-purity spherical magnesia-alumina spinel nano-powder | 大连交通大学 | 2022-02-08 | — | — | CN | disclosed |
| CN-109983017-B | Preparation method and intermediate of pyrimidone heteroaryl derivative | 江苏恒瑞医药股份有限公司 | 2021-11-12 | — | — | CN | disclosed |
| CN-113388319-A | High-wear-resistance chair | 宁波市鑫晟工贸实业有限公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-112042005-A | Separator having a separator layer comprising ceramic | 新罗纳米技术有限公司 | 2020-12-04 | — | — | CN | disclosed |
| EP-3660017-A1 | METHOD FOR PREPARING PYRIMIDONE HETEROARYL DERIVATIVE AND INTERMEDIATE OF PYRIMIDONE HETEROARYL DERIVATIVE | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2020-06-03 | — | — | EP | disclosed |
| US-20200140434-A1 | METHOD FOR PREPARING PYRIMIDONE HETEROARYL DERIVATIVE AND INTERMEDIATE OF PYRIMIDONE HETEROARYL DERIVATIVE | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2020-05-07 | — | — | US | disclosed |
| EP-1051461-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR, William C. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999066009-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR WILLIAM C (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0954558-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR, William C. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1998026028-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 1998-06-18 | — | — | WO | disclosed |
| US-5068291-A | Method of preparing pressure sensitive adhesives with accelerated cure rate | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1991-11-26 | — | — | US | disclosed |
| EP-0183495-A1 | Pressure sensitive adhesives | BP Chemicals Limited (GB) | 1986-06-04 | — | — | EP | disclosed |
| US-4430257-A | MIXING WITH GLASS-FORMING, PARTIALLY HYDROLYZED SILICON AND METAL COMPOUND MIXTURE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1984-02-07 | — | — | US | disclosed |
| US-4292231-A | CARBOXY AND CARBAMATE-FUNCTIONAL VINYL INTERPOLYMER | ASHLAND OIL, INC. (US) | 1981-09-29 | — | — | US | disclosed |
| US-4005247-A | ACRYLATE INTERPOLYMER, METAL ALKOXIDE | ASHLAND OIL, INC. (US) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11306085-B2 | Method for preparing pyrimidone heteroaryl derivative and intermediate of pyrimidone heteroaryl derivative | TYMP, UMPS, DPYD | MAPT 3916/4885GAA 1647/4885L3MBTL1 4657/4885 |
| US-20200140434-A1 | METHOD FOR PREPARING PYRIMIDONE HETEROARYL DERIVATIVE AND INTERMEDIATE OF PYRIMIDONE HETEROARYL DERIVATIVE | UMPS, TYMP, DHPS | MAPT 4062/4885GAA 1187/4885L3MBTL1 4550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.